Nexalin Technology is a neurohealth company offering FDA-cleared, non-invasive brainwave-based treatments designed to alleviate anxiety and insomnia and improve brain health. Their solution involves a frequency-related waveform that interacts with deep brain centers, enabling symptom relief without medications. The company targets healthcare providers and patients in the United States, promoting virtual clinics and at-home treatment options. Nexalin emphasizes research-backed brain health approaches and regular patient education through investor and clinical information channels.
No recent news for this company.
No recent deals for this company.